A Phase I Dose Escalation Study of BKM120 With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Sponsor and Collaborators     
Novartis Pharmaceuticals
 
Contact
Novartis Pharmaceuticals     
+1(800)340-6843

Investigator
Novartis Pharmaceuticals


Continue Reading

ClinicalTrials.gov Identifier
NCT01473901